-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,560.35(%) -
Trent
2,815.00 3,507.32(%) -
Raymond
1,024.00 869.05(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 521.75(%) -
One 97
1,829.50 1,759.05(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,673.50(%) -
Britannia Inds.
4,946.05 5,000.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Rossari Biotech Ltd Chemicals
- Indian Private
- BSE Code : 72633.0
- ISIN : INE02A801020
-
Today’s Low
448.00 -
Today’s High
461.20
-
Open
454.95 -
Perv Close
452.10 -
52W Low
375.00 -
52W High
690.30
Key Indicators
-
P/E(TTM)
16.55
-
Mar.Cap (₹Cr.)
2,489.97
-
Div & Yield %
0.11
-
Book Value(₹)
219.97
-
Debt-Equity Ratio
-0.58
-
AGM Date
10-Sep-2026
-
EPS
27.24
-
P/E Ratio
16.55
Financials Ratios
-
Debt-Equity Ratio
0.10
-
Mar.Cap (₹Cr.)
2,489.97
-
RONW (%)
13.32
-
ROCE (%)
18.16
Score Board
-
Equity (₹ in Cr.)
11.08
-
BV (₹)
220.00
-
Sales( ₹ in Cr.)
1,752.07
-
NP (in Cr.)
127.64
-
NP Var(%)
12.0
-
Div%
25.0
-
CPS (₹)
28.60
-
EPS (₹)
23.00
-
Traded Value (₹ in Lakhs)
2,497.44
-
52 Week High
690.30
-
52 Week Low
375.00
-
Price BSE
451.0
-
Price NSE
450.00
-
Market Capital( in Cr.)
2,497.44
-
P/C Ratio
15.80
-
P/E Ratio
19.60
-
Price Vs.BV
23.00
-
20-Jul-2026( 01:32)
Hot Pursuit - Rossa... - <P> On the expenditure front,...
-
18-Jul-2026( 05:25)
Results - Announcements - Rossa... - Net profit of Rossari Biotech...
-
13-Jul-2026( 10:02)
Corporate News - Rossa... - Rossari Biotech will hold a m...
-
19-Jun-2026( 10:01)
Corporate News - Rossa... - Rossari Biotech announced tha...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,752.07 | 1,431.63 | 1,202.91 | 975.17 | 1,072.84 | 690.41 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,752.07 | 1,431.63 | 1,202.91 | 975.17 | 1,072.84 | 690.41 |
| Other Income | 27.01 | 5.74 | 6.77 | 3.60 | 12.70 | 9.72 |
| Stock Adjustments | -1.93 | 17.04 | 13.58 | 12.97 | 10.34 | 7.22 |
| Total Income | 1,777.15 | 1,454.41 | 1,223.26 | 991.74 | 1,095.88 | 707.35 |
| EXPENDITURE : | ||||||
| Raw Materials | 1,304.89 | 1,064.12 | 910.72 | 717.28 | 830.27 | 458.86 |
| Power and Fuel Cost | 5.84 | 3.41 | 3.01 | 2.80 | 2.80 | 2.40 |
| Employee Cost | 69.46 | 60.01 | 51.46 | 57.35 | 43.53 | 36.66 |
| Other Manufacturing Expenses | 80.77 | 71.29 | 44.25 | 38.04 | 40.25 | 27.75 |
| Selling and Administration Expenses | 83.28 | 61.24 | 39.64 | 42.23 | 33.49 | 37.96 |
| Miscellaneous Expenses | -2.44 | 2.36 | 6.14 | 7.80 | 10.05 | 12.67 |
| Employee Benefit Expenses | 69.46 | 60.01 | 51.46 | 57.35 | 43.53 | 36.66 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,541.80 | 1,262.44 | 1,055.23 | 865.49 | 960.39 | 576.29 |
| Operating Profit | 235.35 | 191.97 | 168.02 | 126.25 | 135.50 | 131.06 |
| Interest | 13.35 | 9.58 | 9.70 | 4.62 | 2.55 | 2.99 |
| Gross Profit | 222.00 | 182.39 | 158.32 | 121.63 | 132.95 | 128.07 |
| Depreciation | 30.93 | 27.69 | 24.19 | 25.98 | 26.27 | 22.07 |
| Profit Before Tax | 191.07 | 154.70 | 134.13 | 95.65 | 106.68 | 106.00 |
| Current Tax | 44.91 | 42.19 | 36.16 | 25.97 | 28.72 | 27.53 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.32 | -2.23 | -1.67 | -1.71 | -1.51 | -0.63 |
| Reported Net Profit | 142.84 | 114.74 | 99.65 | 71.39 | 79.47 | 79.10 |
| Extraordinary Items | 15.20 | 1.24 | 2.20 | 0.42 | 1.42 | 0.32 |
| Adjusted Net Profit | 127.64 | 113.50 | 97.45 | 70.97 | 78.05 | 78.78 |
| Adjustment below Net Profit | -0.05 | -0.28 | -0.01 | 0.34 | 0.01 | 0.13 |
| P & L Balance brought forward | 588.68 | 476.98 | 380.11 | 311.13 | 234.40 | 157.71 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 2.77 | 2.77 | 2.76 | 2.75 | 2.75 | 2.54 |
| P & L Balance carried down | 728.70 | 588.68 | 476.98 | 380.11 | 311.13 | 234.40 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| Dividend Per Share(Rs) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Earnings Per Share-Unit Curr | 25.79 | 20.72 | 18.04 | 12.94 | 14.44 | 15.23 |
| Earnings Per Share(Adj)-Unit Curr | 25.79 | 20.72 | 18.04 | 12.94 | 14.44 | 15.23 |
| Book Value | 220.00 | 194.56 | 173.83 | 155.69 | 142.50 | 77.88 |
| Book Value(Adj)-Unit Curr | 220.00 | 194.56 | 173.83 | 155.69 | 142.50 | 77.88 |
